Skip to content
Companies

Genomenon

Curated literature evidence for interpreting gene variants

Raised to date

$6M

of $10M offered across 1 Form D filing

Still open
$4M
Investors
30
Last filed
Jul 30, 2026

About

Genomenon is an Ann Arbor genomic intelligence company that structures biomedical literature into searchable, actionable genomic evidence. Founded in 2014 out of the University of Michigan, it combines AI-driven indexing of millions of full-text articles with expert scientific curation to link genes, variants, diseases, phenotypes and therapies. Its platforms are used by clinical diagnostic laboratories and biopharmaceutical companies, including Mayo Clinic, Quest Diagnostics, Myriad Genetics and the NHS.

Rather than a general literature search, Genomenon indexes genomic associations at the variant level across more than 10 million full-text articles and layers expert curation on top, so labs get evidence tied to a specific variant instead of a reading list.

Funding

  • EquityFiled Jul 30, 2026Form D
    $6M/ $10M

Product

Mastermind Genomic Intelligence Platform

Genomic intelligence software platform

A germline variant interpretation platform that surfaces indexed and curated literature evidence for more than 26 million genomic variants, with an AI-powered search integration launched in 2025.

  • Variant-level indexing across more than 10 million full-text articles
  • Evidence on over 26 million genomic variants
  • AI-powered genomic search integration

Built for

Clinical diagnostic laboratories and biopharmaceutical companies running precision medicine and drug development programs

People on file